Niche product
Rimegepant sulfate
Tablet (differentiated) · Migraine (acute treatment)
Product data
- Dosage form
- Tablet (differentiated)
- Dosage-form group
- Oral solid
- Therapeutic area
- Migraine (acute treatment)
- Reference product
- Orally disintegrating tablet eq. 75 mg base
- Status
- Under development
- Development stage
- 2 of 5 · Development
- Portfolio
- Niche product
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · ganesan@kmshc.com · +91 97898 75194V-23